Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$53,313,458
-$27,214,945 QoQ
Shares Held
421,984
-27.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#201
of 2,266 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. GILD ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
282,442 | $71,073,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
421,984 | $53,313,458 | |
| 3 | NVS |
Novartis AG
|
317,429 | $49,747,472 | |
| 4 | AMGN |
Amgen Inc
|
108,134 | $39,157,483 | |
| 5 | SNY |
Sanofi
|
674,143 | $28,758,939 | |
| 6 | NVO |
Novo Nordisk A S
|
134,460 | $6,446,012 | |
| 7 | JNJ |
Johnson & Johnson
|
3,288 | $835,053 | |
| 8 | PFE |
Pfizer Inc
|
27,801 | $669,448 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,313,458 | 421,984 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $80,528,403 | 577,803 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $71,653,033 | 583,779 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $63,766,947 | 574,477 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $66,186,728 | 596,976 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $32,606,100 | 290,996 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,155,179 | 12,506 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,048,503 | 12,506 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $858,036 | 12,506 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $912,988 | 12,464 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $973,983 | 12,023 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $21,385,103 | 285,363 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $19,933,616 | 258,643 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,215,510 | 14,650 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,249,375 | 14,553 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,001,968 | 16,242 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $987,847 | 15,982 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $930,273 | 15,648 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,118,774 | 15,408 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,076,248 | 15,408 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,210,903 | 17,585 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,331,184 | 20,597 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||